# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 2B


The holder of a manufacturing authorisation (POC) shall not use premises other than the POC (IMP) control site and the sites specified in the POC (IMP) master file for the purposes specified in paragraph 2(a).

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/paragraph/2B (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/paragraph-2B
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.